Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Capital Leases: 2016-2024

Historic Capital Leases for Lifecore Biomedical (LFCR) over the last 8 years, with May 2024 value amounting to $3.2 million.

  • Lifecore Biomedical's Capital Leases rose 0.03% to $3.2 million in Q2 2024 from the same period last year, while for May 2024 it was $3.2 million, marking a year-over-year increase of 0.03%. This contributed to the annual value of $3.2 million for FY2024, which is 0.03% up from last year.
  • According to the latest figures from FY2024, Lifecore Biomedical's Capital Leases is $3.2 million, which was up 0.03% from $3.2 million recorded in FY2023.
  • Over the past 5 years, Lifecore Biomedical's Capital Leases peaked at $26.4 million during FY2020, and registered a low of $12,000 during FY2022.
  • For the 3-year period, Lifecore Biomedical's Capital Leases averaged around $2.1 million, with its median value being $3.2 million (2023).
  • Data for Lifecore Biomedical's Capital Leases shows a peak YoY spiked of 26,683.33% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Lifecore Biomedical's Capital Leases stood at $26.4 million in 2020, then reached $12,000 in 2022, then spiked by 26,683.33% to $3.2 million in 2023, then grew by 0.03% to $3.2 million in 2024.